DOCSLIB.ORG

Acetaminophen MEDICATION REFERENCE CARD

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acetaminophen MEDICATION REFERENCE CARD NAPA COUNTY EMS AGENCY Acetaminophen MEDICATION REFERENCE CARD • Adults with: • Mild to moderate pain unresponsive to BLS control measures. • Severe pain as an adjunct to Fentanyl INDICATION - • Age < 15 years old. • Known hypersensitivity to acetaminophen CONTRA • Severe hepatic impairment or severe active liver disease INDICATION • • Insomnia Nausea • • Constipation Vomiting SIDE EFFECTS • • Pruritus Headache • 1000 mg in 100 mL NS IV drip over 20 minutes DOSE • ADULT 100mL/20 min 10 gtts/mL set = 50 gtts/min = 1 Drip/1.2 sec ATRIC ***NOT LOCALLY INDICATED FOR PEDIATRIC PATIENTS*** PEDI • Patients with hepatic impairment/disease • Patients with severe hypovolemia • Patients with alcoholism • Patients with severe renal impairment CAUTION • Patients with chronic malnutrition • The precise mechanism of the analgesic and antipyretic properties of acetaminophen is not established but is thought to primarily involve central actions. ACTIONS • AP-13: Pain Management GUIDELINE Effective Date: 07-01-2018 Revised Date: 07-01-2018 Page 1 of 1 NAPA COUNTY EMS AGENCY Adenosine MEDICATION REFERENCE CARD • Narrow Complex Tachycardia • PSVT Including PSVT associated with WPW (Wolff-Parkinson-White syndrome). INDICATION • - 2nd- or 3rd-degree atrioventricular (AV) block • A-Fib, A-Flutter, Wide-Complex Tachycardia • Sick Sinus Syndrome • Stimulant induced tachycardia CONTRA INDICATION • Poisoning induced Tach • Chest pressure • Arrhythmias • • Nausea Facial flushing SIDE • Conduction delay (asystole) for several • Bronchospasm EFFECTS seconds C-06: Supraventricular Tachycardia • Initial: 6mg rapid IV bolus over 1-2 sec • Repeat Administration: If not converted to sinus rhythm w/in 1-2 min, give 12 mg rapid IV DOSE ADULT bolus; may give second 12mg dose if required • Follow each bolus w/ a rapid saline flush • See Pediatric Medication Reference Cards PEDIATRIC • May produce short-lasting 1st-, 2nd-, or • D/C if severe respiratory difficulties 3rd-degree heart block; institute develop. appropriate therapy PRN. • Caution in elderly. • Do not give additional doses if high-level • Does not convert A-fib/flutter, or block develops on 1st dose. ventricular tachycardia to normal sinus • Caution w/ obstructive lung disease not rhythm. CAUTION associated w/ bronchoconstriction (e.g., • A transient modest slowing of ventricular emphysema, bronchitis). response may occur immediately • Caution w/ bronchoconstriction/ following administration in the presence of bronchospasm (e.g., asthma). A-fib/flutter. • Endogenous nucleoside; slows conduction time through AV node, can interrupt reentry pathways through the AV node, and can restore normal sinus rhythm in patients with PSVT, including PSVT associated w/ Wolff-Parkinson-White syndrome. ACTIONS • C-06: Supraventricular Tachycardia • P-06: Pediatric Symptomatic Tachycardia GUIDELINE Effective Date: 01-01-2018 Revised Date: 01-01-2018 Page 1 of 1 NAPA COUNTY EMS AGENCY Albuterol MEDICATION REFERENCE CARD • Relief of bronchospasm in patients w/ reversible obstructive airway disease and acute attacks of bronchospasm (i.e., chronic obstructive pulmonary disease, asthma, and allergic reaction). • Suspected hyperkalemia in crush injury patients. INDICATION - • Patients complaining of cardiac chest pain • Known Hypokalemia CONTRA INDICATION • Tremors • Nausea • Dizziness • Headache SIDE • • Nervousness Insomnia EFFECTS M-03: Respiratory Distress - Bronchospasm M-07: Allergic Reaction/Anaphylaxis • 5mg in 6 mL of NS. Can be administered • 5mg in 6 mL of NS. Can be administered via handheld nebulizer, mask, or in-line with via handheld nebulizer, mask, or in-line BVM or CPAP. with BVM or CPAP. M-04: Respiratory Distress - Pulmonary T-04: Crush Syndrome DOSE ADULT Edema/Congestive Heart Failure • 5mg in 6 mL of NS. Can be administered • 5mg in 6 mL of NS. Can be administered via handheld nebulizer, mask, or in-line via handheld nebulizer, mask, or in-line with with BVM or CPAP. BVM or CPAP. • See Pediatric Medication Reference Cards PEDIATRIC • Caution w/ cardiovascular (CV) disorders (especially coronary insufficiency, cardiac arrhythmias, and HTN). CAUTION S • Acts on Beta-2 receptors to potentiate bronchial dilation and bronchial smooth muscle relaxation. It has minimal Alpha and Beta-1 stimulation and also acts as a CNS stimulant. It shifts potassium intracellularly to reduce serum levels. ACTION • M-03: Respiratory Distress – • M-07: Allergic Reaction/Anaphylaxis Bronchospasm • T-04: Crush Syndrome • M-04: Respiratory Distress - Pulmonary • P-07: Pediatric Allergic Reaction/ Edema/Congestive Heart Failure GUIDELINE Anaphylaxis Effective Date: 01-01-2018 Revised Date: 01-01-2018 Page 1 of 1 NAPA COUNTY EMS AGENCY Amiodarone MEDICATION REFERENCE CARD • Ventricular Fibrillation • Ventricular Tachycardia INDICATION - • Cardiogenic shock, marked sinus bradycardia, 2nd- or 3rd-degree atrioventricular (AV) block unless a functioning pacemaker is available. CONTRA INDICATION • Hypotension • Liver function abnormality • asystole/cardiac arrest/pulseless electrical • nausea activity SIDE • Ventricular Tachycardia • cardiogenic shock EFFECTS • AV block • CHF C-03: Ventricular Fibrillation/Pulseless Ventricular C-05: Wide-Complex Tachycardia Tachycardia • Add 150mg to 100 mL of NS and infuse • total contents over 10 minutes 300mg IV/IO, followed by a 20 mL NS flush DOSE ADULT • Repeat once at 150 mg IV/IO, followed by a 20 mL NS flush. • See Pediatric Medication Reference Cards • See Pediatric Cardiac Arrest Dosing Reference Cards PEDIATRIC • Monitor for hypotension, bradycardia, AV block, hepatic injury, centrolobular confluent hepatocellular necrosis, worsening of existing or precipitation of new arrhythmia, pulmonary toxicity, ARDS, anaphylactic/anaphylactoid reactions, and other adverse reactions. • May prolong QT intervals so do not use with Procainamide. Watch for negative inotropic CAUTION effects. • Decreases AV conduction velocity and sinus node function and also includes alpha and beta adrenergic blocking properties. It also prolongs the effective refractory period. ACTIONS • C-03: Ventricular Fibrillation/Pulseless • P-03: Pediatric Ventricular Fibrillation/ Ventricular Tachycardia Pulseless Ventricular Tachycardia • C-05: Wide-Complex Tachycardia • P-06: Pediatric Symptomatic Tachycardia GUIDELINE Effective Date: 01-01-2018 Revised Date: 01-01-2018 Page 1 of 1 NAPA COUNTY EMS AGENCY Aspirin MEDICATION REFERENCE CARD • Chest pain with suspected ACS • Acute pulmonary edema with suspected ACS INDICATION - • Active GI bleeding. • Children < 12 years old • Hemorrhagic Stroke CONTRA • Hypersensitivity to this drug or non-steroidal anti-inflammatory. INDICATION • Tinnitus – (only in overdoses) • Vomiting • Stomach irritation • Petechiae (with chronic use) SIDE • • Nausea GI Bleeding EFFECTS M-04: Respiratory Distress – Pulmonary C-09: Suspected Acute Coronary Syndrome Edema/Congestive Heart Failure • 162 mg or two 81 mg tablets PO (one • 162 mg or two 81 mg tablets PO (one time dose). DOSE ADULT time dose). • Have patient chew if possible. • Have patient chew if possible. ***NOT LOCALLY INDICATED FOR PEDIATRIC PATIENTS*** PEDIATRIC • May potentiate with Coumadin or other blood thinners. Acceptable to give one time dose • Use with caution in patients with pregnancy, asthma or recent surgery. AUTION C • Reduces the loss of myocardium in MI. • Inhibits prostaglandin synthesis for anti-inflammatory effect. • Aspirin blocks the formation of Thromboxane A2, which causes platelets to aggregate. ACTIONS • Aspirin blocks pain impulses in the CNS. • C-09: Suspected Acute Coronary Syndrome • M-04: Respiratory Distress – Pulmonary Edema/Congestive Heart Failure GUIDELINE Effective Date: 01-01-2018 Revised Date: 01-01-2018 Page 1 of 1 NAPA COUNTY EMS AGENCY Atropine Sulfate MEDICATION REFERENCE CARD • Symptomatic bradycardia • Poisoning/Overdose from organophosphates or carbonates INDICATION - • Tachycardia • Hypersensitivity • Narrow-angle glaucoma CONTRA INDICATION • Tachycardia • Dry mouth SIDE • Blurred vision EFFECTS • Photophobia C-04: Symptomatic Bradycardia M-09: Poisoning/Overdose • 0.5 mg IV/IO. Repeat every five (5) • 2.0 mg IV/IO. If not tachycardia or pupil minutes to a total dose of 3mg. dilation, repeat 2.0mg IV until signs of DOSE ADULT atropinization appear (dilated pupils, mild tachycardia). • See Pediatric Medication Reference Cards PEDIATRIC • Elderly: Start at lower end of dosing range. CAUTION • Anticholinergic; inhibits muscarinic actions of acetylcholine on structures innervated by postganglionic cholinergic nerves, and on smooth muscles, which respond to endogenous acetylcholine but are not so innervated. Major action is by competitive or surmountable ACTIONS antagonism. • C-04: Symptomatic Bradycardia • M-09: Poisoning/Overdose • P-05: Pediatric Symptomatic Bradycardia GUIDELINE Effective Date: 01-01-2018 Revised Date: 01-01-2018 Page 1 of 1 NAPA COUNTY EMS AGENCY Calcium Chloride MEDICATION REFERENCE CARD • Cardiac arrest when hyperkalemia is suspected in renal dialysis patients. • Suspected hyperkalemia in crush injury patients. INDICATION - • History of digitalis use, unless in the setting of cardiac arrest. • Respiratory failure • Hypercalcemia CONTRA INDICATION • Peripheral vasodilation SIDE • Localized “burning” sensation EFFECTS C-02: Asystole/Pulseless Electrical Activity T-04: Crush Syndrome • IV/IO slow IVP 1G of 10% calcium • 1 gm slow IVP over 60 seconds chloride DOSE ADULT ***Physician Order Only*** ***NOT LOCALLY INDICATED FOR PEDIATRIC PATIENTS*** PEDIATRIC • Necrotic to tissue, avoid
Load more

Recommended publications
  • Scope of Practice Statements
    Scope of Practice Statements Emergency Medical Services Authority California Health and Human Services Agency EMSA # 300 November 2017 HOWARD BACKER, MD, MPH, FACEP DIRECTOR DANIEL R. SMILEY CHIEF DEPUTY DIRECTOR SEAN TRASK DIVISION CHIEF EMSA # 300 Released November 2017 EMSA #300 • Page 1 Table of Contents Introduction ........................................................................................................................................... 4 The EMS Authority ................................................................................................................................ 4 Local EMS Agencies ............................................................................................................................. 4 California EMS Personnel Levels .......................................................................................................... 4 Reading the Scope of Practice Pages .................................................................................................. 5 Airway and Breathing ............................................................................................................................ 6 Airway Suctioning .............................................................................................................................. 7 Automatic Transport Ventilator .......................................................................................................... 8 Bag Valve Mask – BVM ....................................................................................................................
    [Show full text]
  • The Emergency Severity Index
    The Emergency Severity Index Jassin M. Jouria, MD Dr. Jassin M. Jouria is a medical doctor, professor of academic medicine, and medical author. He graduated from Ross University School of Medicine and has completed his clinical clerkship training in various teaching hospitals throughout New York, including King’s County Hospital Center and Brookdale Medical Center, among others. Dr. Jouria has passed all USMLE medical board exams, and has served as a test prep tutor and instructor for Kaplan. He has developed several medical courses and curricula for a variety of educational institutions. Dr. Jouria has also served on multiple levels in the academic field including faculty member and Department Chair. Dr. Jouria continues to serve as a Subject Matter Expert for several continuing education organizations covering multiple basic medical sciences. He has also developed several continuing medical education courses covering various topics in clinical medicine. Recently, Dr. Jouria has been contracted by the University of Miami/Jackson Memorial Hospital’s Department of Surgery to develop an e- module training series for trauma patient management. Dr. Jouria is currently authoring an academic textbook on Human Anatomy & Physiology. Abstract One of the main challenges encountered by emergency departments is determining how to appropriately triage patients. Although some systems only take into account a single determining factor, the Agency for Healthcare Research and Quality promotes a system that considers both the acuity of patients’ health care problems as well as the number of resources needed to treat them. This system provides emergency departments with a unique tool to ensure that the most at-risk patients are being seen and treated in the most efficient manner.
    [Show full text]
  • Emergency Medical System 2021 Patient Treatment Protocols
    2021 Patient Treatment Protocols Effective January 1, 2021 CONTENTS Table of Contents Preface Section ...........................................................................................................00.000 EMS Provider Scope of Practice and Nomenclature .....................................................00.010 Death in the Field ........................................................................................................00.020 Dying and Death, POLST, Do Not Attempt Resuscitation Orders ..............................00.030 Medical Control for Drugs and Procedures ..................................................................00.040 Treatment ......................................................................................................... Section 10.000 Abdominal Pain ...........................................................................................................10.010 Altered Mental Status and Coma ..................................................................................10.020 Anaphylaxis and Allergic Reaction ................................................................................10.030 Burns ...........................................................................................................................10.040 Cardiac Arrest ..............................................................................................................10.050 Emergency Medical Responder/EMT Paramedic/EMT-Intermediate Quick Reference to Pediatric Drugs Cardiac Dysrhythmias ..................................................................................................10.060
    [Show full text]
  • North Port Fire Rescue October 2013 Monthly Report
    North Port Fire Rescue October 2013 Monthly Report b. Fire: Personnel expenses are at 8%, Operations are slightly higher at 10.8% due to encumbrances that are issued for annual purchase orders for products and services. We have no Capital expenses at this time. 3. Grants: a. We are waiting on several closeout letters on grants. Most of these have been slowed because of the sequestration and federal shut down. b. The big news is the that FEMA Assistance to Firefighters Grant program period that was due to open in April was finally announced and will open in November. We have three proposed grants to submit for this cycle. 4. Emergency Calls: a. October, with 506 emergency calls, was a big jump in call volume over the month of September at nearly 15%. However, compared to October of 2012 we were up only slightly at 2%. This is the beginning of our seasonal shift in call volume. 5. Special Events: a. Staff participated in numerous school fall festivals, a fire safety event at Home Depot, lectured for Government Week in schools, helped with the High School Homecoming, served lunch at the schools during School Lunch Week, and several other activities. b. North Port Fire Rescue members also competed in the annual Morton’s Firefighter Chili Cook-off taking first place in the Judges Choice and the Peoples’ Choice. 6. Training: a. Fire Training this month included a study of response to hybrid vehicle fires and crashes as well as several practical sessions on basic firefighting practices. b. EMS Training was focused on Pediatric patient care and the practical skill was Intraosseous Infusion (IV infusion directly into the bone marrow).
    [Show full text]
  • Adult Intraosseous Procedure Always Use Standard Precautions
    July 2018 COUNTY OF MARIN EMS ALS PR 2 ADULT INTRAOSSEOUS PROCEDURE ALWAYS USE STANDARD PRECAUTIONS INDICATIONS ▪ Patient in extremis, cardiac arrest, profound hypovolemia, or septic and in need of immediate delivery of medications / fluids and immediate IV access is not possible CONTRAINDICATIONS ▪ Absolute contraindications: ▪ Recent fracture of involved bone (less than 6 weeks) ▪ Vascular disruption proximal to insertion site ▪ Inability to locate landmarks ▪ Relative contraindications: ▪ Infection or burn overlying the site ▪ Congenital deformities of the bone ▪ Metabolic bone disease EQUIPMENT ▪ Intraosseous infusion needle and/ or mechanical device ▪ Commercially prepared chlorhexidine with alcohol swab or ampule. If patient has allergy to chlorhexidine, use alcohol swab only. ▪ Sterile gauze pads ▪ 10-12 ml syringe filled with 10 ml saline ▪ IV NS solution and tubing with 3-way stopcock ▪ Supplies to secure infusion ▪ Pressure bag ▪ Lidocaine 2% (Preservative Free) PROCEDURE ▪ Aseptic technique must be followed at all times ▪ Position and stabilize chosen site ▪ Prepare insertion site using aseptic technique ▪ Air or gauze dry ▪ Insert IO needle according to manufacturer’s directions ▪ Confirm placement ▪ Attach primed extension set and flush with 10 ml of saline ▪ If patient awake and/or responsive to pain, infuse 2% Lidocaine 20-40 mg over 30-60 seconds. Wait 30-60 seconds before fluid infusion. May repeat Lidocaine in 15 minutes if needed. ▪ If resistance is met, remove needle, apply pressure to site and attempt at secondary site ▪ Attach pre-flooded IV tubing ▪ Stabilize as recommended by manufacturer ▪ Fluid administration requires pressure bag ▪ Monitor insertion site and patient condition Page 1 of 1 October 2017 COUNTY OF MARIN EMS ALS PR 3 ORAL ENDOTRACHEAL INTUBATION PROCEDURE ALWAYS USE STANDARD PRECAUTIONS INDICATION .
    [Show full text]
  • Intraosseous Infusion
    INTRAOSSEOUS INFUSION Brian G. LaRocco, BS, Henry E. Wang, MD ABSTRACT peripheral (17%).7 We review the history, anatomy, Establishing vascular access is vital in the resuscitation of technique, and prehospital clinical application of IOI. critically-ill children and adults. Intraosseous infusion (IOI) We recommend that IOI be considered as a viable is a viable route for providing vascular access when tradi- route for vascular access during resuscitation in the tional intravenous methods cannot be accomplished. IOI is prehospital setting. relatively easy to perform and is a standard recommended intervention for the resuscitation of both adults and chil- HISTORY OF IOI dren. The authors review the history, anatomy, technique, and clinical application of IOI. They also highlight the use of Since the 1830s, the IV route has been used to admin- IOI in the prehospital setting. Key words: intraosseous; infu- ister fluids. In 1922, Drinker et al. examined the circu- sion; needles; vascular access; prehospital; resuscitation. lation of the sternum and suggested that it be used as PREHOSPITAL EMERGENCY CARE 2003;7:280–285 a route for blood transfusion.8 In 1940 Henning used the sternum to transfuse a patient with granulocy- Vascular access is a vital task in the resuscitation of topenia.9 Tocantins and O’Neill established in 1941 the critically ill.1,2 Although peripheral intravenous that the bone marrow cavity of a long bone was a pos- (IV) access is the traditional method for gaining vas- sible site of vascular access; they showed that after cular access, this route can be challenging to achieve in injection of 5 mL of saline in the long bone of a rabbit, victims of circulatory collapse.
    [Show full text]
  • 2017 the Science and Fundamentals of Intraosseous Vascular Access Including Frequently Asked Questions
    EZ-IO Intraosseous Vascular from TELEFLEX Access System Arrow® EZ-IO® Intraosseous Vascular Access System 2017 The Science and Fundamentals of Intraosseous Vascular Access including Frequently Asked Questions Teleflex Global Research and Scientific Services, a Division of Clinical and Medical Affairs 1 2 2017 Third Edition Introduction . 8 Indications/Contraindications and General Intraosseous (IO) Use . 10 When can the Arrow® EZ-IO® Intraosseous Vascular Access System from Teleflex be used? . 10 In what type of clinical scenarios is IO vascular access used? . 10 Can the Arrow® EZ-IO® Intraosseous Vascular Access System Device be used in the sternum? . 11 What is off-label use of the Arrow® EZ-IO® Device? . 11 Can nurses and medics perform IO device insertions? . 11 Do professional organizations support IO vascular access for clinical applications? . 11 Is special training or certification required prior to using the EZ-IO® Device? . 12 Anatomy and Physiology of the IO Space . .12 How does the IO vascular access route work? . 12 Which insertion site works best? . 12 Anatomy . 13 Physiology . 13 Intramedullary pressure . 14 During CPR: guidelines . 14 Preclinical studies . 15 Clinical studies . 17 Technique/Training . .21 How should the skin be prepared for IO insertion? . 21 Is a local anesthetic necessary for EZ-IO® Device insertion in an alert patient? . 21 How is appropriate EZ-IO® Needle Set length determined? Can the “pediatric” needle sets be used in adults, or “adult” needle sets in pediatric patients? . 21 How deep should the EZ-IO® Needle Set be inserted into the bone? . 22 3 What if the driver seems to be losing power and slows down? .
    [Show full text]
  • Intraosseous Anesthesia in Hemodynamic Studies in Children with Cardiopathy
    Rev Bras Anestesiol ARTIGO CIENTÍFICO 2011; 61: 1: 41-49 Artigo Científico Anestesia Intraóssea em Estudo Hemodinâmico em Criança Cardiopata Ana Cristina Aliman 1, Marilde de Albuquerque Piccioni 2, João Luiz Piccioni, TSA 3, José Luiz Oliva, TSA 3, José Otávio Costa Auler Júnior, TSA 4 Resumo: Aliman AC, Piccioni MA, Piccioni JL, Oliva JL, Auler Júnior JOC – Anestesia Intraóssea em Estudo Hemodinâmico em Criança Car- diopata. Justificativa e objetivos: O acesso intraósseo (IO) tem sido utilizado com bons resultados em situações de emergência quando não há acesso venoso disponível para a administração de fluidos e fármacos. O objetivo do presente estudo foi avaliar se o acesso IO é uma técnica útil para a administração de anestesia e fluidos no estudo hemodinâmico quando é impossível obter acesso periférico. Este estudo foi realizado na Uni- dade de Hemodinâmica de um hospital universitário, com 21 lactentes que apresentavam doença cardíaca congênita agendados para estudo hemodinâmico diagnóstico. Métodos: Este estudo comparou a efetividade do acesso IO em relação ao EV para a infusão de anestésicos (cetamina, midazolam e fentanil) e fluidos durante estudo hemodinâmico.T empo de indução anestésica, duração do procedimento, tempo de recuperação da anestesia, hidratação e complicações das punções EV e IO foram comparados entre os grupos. Resultados: O tempo de punção foi significativamente menor no grupoI O (3,6 minutos) do que no grupo EV (9,6 minutos). O tempo de início da ação do anestésico foi mais rápido no grupo EV (56,3 segundos) do que no grupo IO (71,3 segundos). Não foram observadas diferenças significa- tivas entre os dois grupos em relação à hidratação (grupo EV 315,5 mL vs.
    [Show full text]
  • New Jersey Ems Field Guide
    NEW JERSEY EMS FIELD GUIDE CHRIS CHRISTIE MARY E. O’DOWD Governor Commissioner 2013 KIM GUADAGNO AUGUST Lt. Governor Contents How to Use the Field Guide 7 Acknowledgments 8 Section 1: General 10 Assessment Tools 10 Pediatric Assessment 18 Geriatric Assessment 25 Communication 27 Documentation 29 Infection Control and Standard Precautions 30 Patient Confidentiality and HIPPA 32 Social Media Tips (e.g., Facebook, Twitter) 32 Patient Refusal 33 Requesting an Air Medical Unit (AMU) 34 Requesting Simultaneous ALS/BLS 35 Section 2: Medical 36 Abdominal Pain, Nausea, and/or Vomiting 36 Abuse and Neglect 38 Allergic Reactions and Anaphylaxis 42 Altered Mental Status 45 Behavioral Emergencies and Psychiatric Disorders 47 Diabetic Emergencies 50 Frostbite 52 Hypoperfusion: Nontraumatic Shock 54 Hyperthermia 56 Hypothermia 58 Near Drowning 60 Pain Management 63 Seizures 65 Stroke and Cerebrovascular Accidents 68 Chest Pain and Acute Myocardial Infarction 70 CPR Guidelines 73 Pediatric Cardiac Arrest 75 Pediatric Bradycardia 76 Pediatric Tachycardia 77 Advanced Cardiac Life Support 78 Wolff-Parkinson-White Syndrome 81 Normal Delivery Childbirth 86 Abnormal Delivery Childbirth 89 Pregnancy Bleeding 91 Neonatal Resuscitation 93 CNS Depressant Poisoning/Overdose 96 Tricyclic Antidepressant Poisoning/Overdose 98 Asthma 100 Chronic Obstructive Pulmonary Disease (COPD) 103 Congestive Heart Failure (CHF) 105 Croup and Epiglottitis 107 Obstructed Airway, Child/Adult 109 Obstructed Airway, Infant 111 Section 3: Trauma 112 Amputation 112 Burns 114 Eye Injuries 118 General Management of Trauma 120 Head and Spine Injuries 123 Orthopedic Injuries 125 Soft Tissue Injuries 128 Trauma Transport Guidelines 130 Section 4: Procedures 133 Cricothyrotomy 133 Epinephrine Auto-Injector 135 Intraosseous Infusion 137 Intubation Checklist 139 Oxygen Administration 142 ST-segment Elevation Myocardial Infarction (STEMI) 143 ACT F.A.S.T.
    [Show full text]
  • Spinal Injection Simulator Lf01036u Instruction Manual
    Other Available Simulators LF00698U Adult Injectable Arm (White) LF03610U Child Airway Management LF00856U Female Catheterization Trainer Head Only LF00901U Prostate Examination LF03611U Child Defibrillation Chest LF00906U Ostomy Care Skin LF00929U Surgical Bandaging LF03612U Child IV Arm LF00957U Enema Administration LF03613U Child Blood Pressure Arm LF00958U Pediatric Injectable Arm LF03614U Child Intraosseous Infusion/ LF00961U Intramuscular Injection Femoral Access Leg Only LF00984U Breast Examination LF03615U Complete Child CRiSis™ LF00995U Arterial Puncture Arm Update Kit LF00997U Adult Injectable Arm (Black) LF03616U Child CRiSis™ Manikin SPINAL INJECTION LF00999U Pediatric Injectable Head LF03617U Deluxe Child CRiSis™ LF01008U Intradermal Injection Arm Manikin with Arrhythmia Tutor LF01012U Heart Catheterization (TPN) LF03620U PALS Update Kit SIMULATOR LF01019U Ear Examination LF03621U Infant Airway Management LF01020U Supplementary Ear Set Trainer Head Only LF01025U Male Cath-Ed I LF03622U Intraosseous Infusion Right LF01036U LF01026U Female Cath-Ed II Leg LF01027U Peritoneal Dialysis LF03623U Infant Airway Management LF01028U Suture Practice Arm Trainer INSTRUCTION MANUAL LF01036U Spinal Injection LF03626U Child Femoral Access LF01037U Hemodialysis Arm Injection Pad Replacement LF01062U Pelvic, Normal & Abnormal LF03632U Child Intraosseous Infusion/ LF01063U Stump Bandaging, Upper Femoral Access Leg on a LF01064U Stump Bandaging, Lower Stand LF01069U Cervical Effacement LF03633U Child Airway Management LF01070U Birthing Station
    [Show full text]
  • POSTOPERATIVE ANALGESIA in PAEDIATRIC DAY CASE SURGERY Dr Manjushree Ray, MD, Associate Professor, N.R.S
    34 Update in Anaesthesia be used as untreated hypotension can seriously damage Morgan P. Spinal anaesthesia in obstetrics (a review). Canadian the unborn infant. Journal of Anaesthesia. 1995;42:1145-63 After delivery of the baby, syntocinon is the oxytocic Ngan Kee WD. Intrathecal pethidine: pharmacology and clinical applications. Anaesthesia and Intensive Care 1998;26:137-146. of choice as it is less likely to produce maternal nausea and vomiting than ergometrine. Ramasamy D, Eadie R. Transient radicular irritiation after spinal anaesthesia with 2% lignocaine. British Journal of Anaesthesia Further reading: 1996, 79, 394-395 Collins C, Gurug A. Anaesthesia for Caesarean section. Update Rawal N, Van Zudert A, Holmstrom B, Crowhurst JA. Combined in Anaesthesia 1998;9:7-17 spinal epidural techniques. Regional Anaesthesia. 1997;5:406-423. Torr GJ, James MFM. The role of the anaesthetist in pre- Williams D. Subarachnoid saddle block using pethidine. Update eclampsia. Update in Anaesthesia 1998;9:17-22 in Anaesthesia 1998;9:47-8 POSTOPERATIVE ANALGESIA IN PAEDIATRIC DAY CASE SURGERY Dr Manjushree Ray, MD, Associate Professor, N.R.S. Medical College, Calcutta-700 014 and Dr. S. M. Basu, MD, DA (London), Editor, Indian Journal of Anaesthesia Paediatric day case surgery was first described in 1909 Neonates. Day case surgery is not contraindicated in full by James Nicoll, who performed 8988 operations as day term neonates - minor procedures like examination under case at the Royal Glasgow Hospital. Since then, day case anaesthesia and incision and drainage can be performed. surgery has continued to grow and now about 50% to Fortunately, these procedures do not produce much 60% of paediatric surgery is performed as outpatients in postoperative pain.
    [Show full text]
  • Intraosseous Infusion Adult and Pediatric– EZIO
    Procedure -8 Intraosseous Infusion – Adult and Pediatric EZIO Page 1 of 7 Intraosseous Infusion Adult and Pediatric– EZIO APPROVED: EMS Medical Director EMS Administrator 1. Goals/Introduction: 1.1 Intraosseous (IO) infusion provides an effective alternative means of providing fluids and medications for severely ill patients in whom intravenous access is not possible. It should be considered in any unconscious or seriously ill or injured person in whom IV access cannot be established in a timely fashion. 1.2 IO can be considered first line attempt for access in patients in cardiopulmonary arrest or patients in extremis when fluids or medications must be administered immediately. 2. Indications: 2.1 Any ALS patient for whom immediate fluid or medication treatment is indicated and shall have at least one of the following: 2.1.1 Altered mental status 2.1.2 Respiratory compromise 2.1.3 Hemodynamic instability 3. Absolute Contraindications: 3.1 Established IV line or if one can be established in a timely fashion 3.2 A patient who does not require immediate fluid or medication therapy. IO insertion shall not be performed for prophylaxis. 3.3 Fracture of bone selected for IO infusion 3.4 Inability to identify landmarks for procedure Issue Date: July 2009 Effective Date: March 1, 2012 Review Date: March 2014 Procedure -8 Intraosseous Infusion – Adult and Pediatric EZIO Page 2 of 7 3.5 Known previous orthopedic procedure or preexisting medical disease (such as tumor or significant peripheral vascular disease) of the bone selected for IO infusion 3.6 Severe burn or infection at the site of insertion 4.
    [Show full text]